Workflow
ChromaDex(CDXC)
icon
Search documents
ChromaDex(CDXC) - 2020 Q4 - Annual Report
2021-03-11 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 26-2940963 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.001 par value per share CDXC The Nasdaq Capital Market Large accelerated filer ☐ Non-accelerated filer ☒ Accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...
ChromaDex(CDXC) - 2020 Q4 - Earnings Call Transcript
2021-03-11 04:12
ChromaDex Corporation (NASDAQ:CDXC) Q4 2020 Earnings Conference Call March 10, 2021 4:30 PM ET Company Participants Brianna Gerber – Vice President-Finance and Investor Relations Rob Fried – Chief Executive Officer Frank Jaksch – Co-Founder and Executive Chairman Kevin Farr – Chief Financial Officer Conference Call Participants Brian Nagel – Oppenheimer Thomas Yip – H.C. Wainwright Destiny Buch – Ladenburg Thalmann Mitch Pinheiro – Sturdivant & Co. Jeff Van Sinderen – B. Riley Bill Dezellem – Tieton Capital ...
ChromaDex Corporation (CDXC) Investor Presentation - Slideshow
2020-12-14 18:19
Investor Presentation Rob Fried Chief Executive Officer Kevin Farr Chief Financial Officer TRU NIAGEN® Nasdaq: CDXC | December 2020 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements reflect the current view about future events. Sta ...
ChromaDex(CDXC) - 2020 Q3 - Earnings Call Transcript
2020-11-05 03:42
ChromaDex Corporation (NASDAQ:CDXC) Q3 2020 Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Brianna Gerber – Vice President-FP&A and Investor Relations Rob Fried – Chief Executive Officer Frank Jaksch – Co-Founder and Executive Chairman Kevin Farr – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Brian Nagel – Oppenheimer Jeff Van Sinderen – B. Riley FBR Ram Selvaraju – H.C. Wainwright Mitchell Pinheiro – Sturdivant & Company JP Mark – Farmhouse Equit ...
ChromaDex(CDXC) - 2020 Q3 - Quarterly Report
2020-11-04 21:55
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 26-2940963 (State incorporation or (I.R.S. Employer Identification No.) orotherjurisdictionof organization) 10900 Wilshire Blvd. Suite 600, Los Angeles, CA (Address of Pr ...
ChromaDex(CDXC) - 2020 Q2 - Earnings Call Transcript
2020-08-09 19:34
ChromaDex Corporation (NASDAQ:CDXC) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Brianna Gerber - Vice President, FP&A & Investor Relations Rob Fried - Chief Executive Officer Frank Jaksch - Founder & Executive Chairman Kevin Farr - Chief Financial Officer Conference Call Participants Jeff Vansen Sinderen - B. Riley Brian Nagel - Oppenheimer Mitchell Pinheiro - Sturdivant JP Mark - Farmhouse Equity Research Matt Dhane - Tieton Capital Management Operator Ladies and gentlem ...
ChromaDex(CDXC) - 2020 Q2 - Earnings Call Presentation
2020-08-07 14:33
ChromaDex Earnings Conference Call Second Quarter 2020 Rob Fried Chief Executive Officer Frank Jaksch Co-Founder / Executive Chairman Kevin Farr Chief Financial Officer Nasdaq: CDXC | August 6, 2020 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-l ...
ChromaDex(CDXC) - 2020 Q2 - Quarterly Report
2020-08-06 20:18
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | |-------------|--------------------------------------------------------------| | | Delaware | | (State or | other jurisdiction of incorporation or organization) | 26-2940 ...
ChromaDex (CDXC) Presents At Lytham Partners Virtual Investor Growth Conference - Slideshow
2020-06-26 17:38
Investor Presentation Rob Fried Chief Executive Officer Kevin Farr Chief Financial Officer TRU NIAGEN Nasdaq: CDXC | June 2020 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements reflect the current view about future events. Statemen ...
ChromaDex(CDXC) - 2020 Q1 - Quarterly Report
2020-05-18 21:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 26-2940963 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 10900 Wilshire Blvd. Suite 600 Los Angeles, California 9002 ...